Adocia Stock London S.E.
Stocks
0QAI
FR0011184241
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.890 EUR | -8.86% |
|
+21.58% | -25.80% |
| 06-08 | Adocia presents Phase 3 study data |  |
| 06-08 | Adocia Presents Full Phase 3 Results For BioChaperone Lispro In Type 2 Diabetes Presented at ADA 86th Scientific Sessions | CI |
| Market Cap | 87.19M 101M 80.29M 75.38M 142M 9.57B 143M 949M 370M 4.68B 380M 372M 16.23B | P/E Ratio 2025 |
-7.44x | P/E Ratio 2026 * | 18x |
|---|---|---|---|---|---|
| Enterprise Value | 44.67M 51.83M 41.13M 38.62M 72.51M 4.9B 73.28M 486M 189M 2.4B 195M 190M 8.32B | EV / Sales 2025 |
31.9x | EV / Sales 2026 * | 1x |
| Free-Float |
90.83% | Yield 2025 * |
-
| Yield 2026 * | - |
| 1 day | -8.86% | ||
| 1 week | +21.58% | ||
| Current month | -2.98% | ||
| 1 month | -4.31% | ||
| 3 months | -15.40% | ||
| 6 months | -25.00% | ||
| Current year | -25.80% |
| 1 week | 4.03 |  | 4.89 |
| 1 month | 3.91 | | 5.14 |
| Current year | 3.91 | | 7.45 |
| 1 year | 3.48 | | 12.24 |
| 3 years | 3.15 | | 16.16 |
| 5 years | 2.8 | | 16.16 |
| 10 years | 2.8 | | 61.28 |
| Manager | Title | Age | Since |
|---|---|---|---|
Olivier Soula
CEO | Chief Executive Officer | 55 | 2023-05-10 |
| Director of Finance/CFO | - | 2024-09-22 | |
Martin Gaudier
CTO | Chief Tech/Sci/R&D Officer | - | 2014-11-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Olivier Soula
BRD | Director/Board Member | 55 | 2013-04-18 |
Gérard Soula
CHM | Chairman | 80 | 2012-02-23 |
| Director/Board Member | 58 | 2013-06-17 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -8.86% | +21.58% | - | - | 100M | |
| -0.71% | -0.29% | +56.45% | +107.18% | 54.92B | |
| -1.22% | +5.01% | +43.38% | +36.69% | 44.31B | |
| -1.43% | +3.47% | -15.83% | -20.48% | 22.96B | |
| -1.99% | -3.55% | -5.97% | +377.60% | 21.12B | |
| -0.20% | +0.94% | +16.65% | -35.80% | 16.31B | |
| -2.38% | -3.38% | +5.53% | -41.88% | 15.19B | |
| -1.70% | -1.68% | +24.79% | +172.92% | 13.32B | |
| -3.10% | +2.69% | +24.46% | - | 12.48B | |
| +0.29% | +5.10% | +75.82% | +105.33% | 11.52B | |
| Average | -2.12% | +2.14% | +25.03% | +87.70% | 23.57B | |
| Weighted average by Cap. | -1.25% | +1.39% | +30.16% | +86.72% |
| 2025 | 2026 * | |
|---|---|---|
| Net sales | 38.39M 44.55M 35.35M 33.19M 62.32M 4.21B 62.98M 418M 163M 2.06B 167M 164M 7.15B | 38.39M 44.54M 35.35M 33.19M 62.31M 4.21B 62.97M 418M 163M 2.06B 167M 164M 7.15B |
| Net income | -13.01M -15.1M -11.98M -11.25M -21.13M -1.43B -21.35M -142M -55.17M -699M -56.67M -55.47M -2.42B | 3.98M 4.61M 3.66M 3.44M 6.45M 436M 6.52M 43.27M 16.86M 214M 17.32M 16.95M 740M |
| Net Debt | -42.52M -49.34M -39.16M -36.76M -69.02M -4.66B -69.75M -463M -180M -2.28B -185M -181M -7.92B | -48.77M -56.59M -44.91M -42.16M -79.16M -5.35B -79.99M -531M -207M -2.62B -212M -208M -9.08B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-16 | 4.390 € | -0.68% | 123 |
| 26-06-15 | 4.420 € | +3.46% | 1,078 |
| 26-06-12 | 4.272 € | +5.01% | 91 |
| 26-06-11 | 4.068 € | +3.25% | 692 |
| 26-06-10 | 3.940 € | -2.04% | 1,073 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ADOC Stock
- 0QAI Stock
Select your edition
All financial news and data tailored to specific country editions
